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This paper discusses the principles of study design and related methodologic issues in environmental epidemiology. Emphasis is given to studies
aimed at evaluating causal hypotheses regarding exposures to suspected health hazards. Following background sections on the quantitative objec-
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Introduction
The purposeofthisartideis to discustheprinci-
ples ofstudy design and related methodologic
issues inenvironmentalepidemiology. Thefocus
is on studies aimed atevaluating csal hypothe-
ses ding eosu to spected health haz-
ards. Because the intended audience for this
document indudes scientists without formal
training in epidemiology, parts ofthis article
highlight basic principles ofepidemiologic
reerc Nevertheless, we also try to summarze
comprehensively the current state ofthe art and
make recommendations forfuturedevelopments
in studydesign. For more tensive trmentof
general research principles and methods in epi-
demiology, the interested reader should consult
available textbooks in this area (1-6). More
detailed exmples ofapplications in environmen-
tl epidemiology may be found in severl other
books, such as those edited by Leaverton (7),
Chiazze et al. (8), Goldsmith (9), and Kopfler
andCraun(10).
Population Parameters
The major quantitative objectives of most epi-
demiologic studies are to estimate two types of
population parameters: the frequency of dis-
ease occurrence in particular populations and
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the effect of a given exposure on disease
occurrencein aparticularpopulation.
Measures of disease frequency involve
the occurrence ofnew cases or deaths (inci-
dence/mortality) or the presence ofexisting
cases (prevalence). In both applications,
the number ofcases is expressed relative to
the size of the population from which the
cases are identified. With incidence mea-
sures, this denominator is the (base) popu-
lation at risk (i.e., individuals who are
eligible to become cases). Thus, the base
population ofa study (or study base) is the
group ofall individuals who, ifthey devel-
oped the disease, would become cases in
the study (3,11,12).
Disease incidence, which is central to the
process ofcausal inference, can be expressed
as a cumulative measure (risk) or as a per-
son-time measure (rate). The cumulative
incidence (incidence proportion) or average
risk in abase population is the probabilityof
someone in that population developing the
disease during a specified period, condi-
tional on not dying first from another dis-
ease (13). The term cumulative incidence
or cumulative incidence rate also is defined
somewhat differently as the integral over the
follow-up period of the hazard (rate) func-
tion (14). The incidence rate or instanta-
neous risk (hazard) is the limitofthe average
risk for a given period, per unit oftime, as
the duration ofthe period approaches zero.
The average rate (incidence density) for a
given period is estimated as the number of
incident events divided by the amount of
person-time experienced bythe base popula-
tion. For example, a rate of 0.001/year
means thatwewould expect one newcase to
occur for every 1000 person-years offollow-
up (e.g., 100 disease-free people followed for
an average of10 years).
Although there are many quantitative
methods for expressing the magnitude ofa
statistical association between two variables
(e.g., exposure status and disease occur-
rence), we are usually interested in a special
class of such measures that reflect the net
effect ofthe exposure on disease occurrence
(i.e., causal parameters). In general, a
causal parameter for a target population is a
hypothetical contrast-in the form ofa dif-
ference or ratio-between what the fre-
quency of disease would be if everyone
were exposed (at a given level) to what the
frequency would be ifeveryone were unex-
posed (often called the reference level)
(15). When this difference for a specific
exposure is not zero (the ratio is not one),
we say that the exposure is a risk factor for
that disease in the target population. In
practice, we estimate causal parameters indi-
rectly bycomparing disease frequency for an
exposed group with disease frequency for an
unexposed group. Epidemiologists typically
estimate the risk or rate ratio (often called
the relative risk) by comparing the exposed
population with an unexposed population.
The key assumption of this statistical
approach is that the risk or rate observed
for the unexposed group is the same (within
confounder strata) as the risk or rate that
would have been observed in the exposed
group if that group had not been exposed
Environmental Health Perspectives Supplements
Volume 101, Supplement 4, December 1993
23MORGENSTERNAND THOMAS
(16). Thus, the (true) risk ratio may be
interpreted as a causal parameter, which is the
number of cases actually occurring in the
exposed (target) population divided by the
number ofcases that would have occurred in
theabsenceofexposure.
Certain measures ofassociation, such as
correlation coefficients and standardized
regression coefficients, do not, in general,
reflect any causal parameters. The reason is
that the magnitude ofthese measures depends
in part on the relative variances ofthe expo-
sure and disease variables, which are influ-
enced bythesamplingstrategy (i.e., noncausal
parameters) (17,18). Another measure of
association, the odds ratio, is used in certain
types ofepidemiologic studies (case-control
designs) to estimate the risk or rate ratio indi-
rectly when we cannot first estimate the inci-
dencerateorriskintheexposedandunexposed
populations (1-619,20).
Problems inEnvironmental
Epidemiology
There are several general problems in envi-
ronmental epidemiology that tend to limit
causal inference and, therefore, shape
design decisions.
Long Latent Periods. The interval
between first exposure to an environmental
risk factor (or the start ofcausal action ofthis
factor) and disease detection (or symptom
onset) may be many years or even decades.
Suchlonglatentperiods arepardydue to lim-
itations ofmedical technologyand incomplete
surveillance for detecting disease; yet they are
also due to a prolonged induction period in
which years are needed for the disease process
to begin (5). The term latent period also is
used more specifically to indicate the hypo-
thetical interval between disease initiation and
detection (5). Refer also to Armenian and
Lilienfeld (21) who discuss altemative defini-
tions oflatency. Unfortunately, long latent
periods produce important practical con-
straints on our ability to estimate exposure
effects. The investigator must either observe
subjects for many years or rely on retrospec-
tive (historical) measurement ofkeyvariables.
Thelatteraltemative maybeinfeasibleforcer-
tain types ofexposures or in certain popula-
tions. Even when feasible, however,
retrospective measurement usually increases
the amount oferrorwith which exposures are
measured (see below). Furthermore, the level
of most environmental exposures and many
extraneous risk factors changes appreciably or
unpredictably over time; long latent periods,
therefore, seriously complicate our ability to
estimateeffects (22).
Errors ofExposure Measurement. A
major challenge in environmental epidemi-
ology is to measure accurately each individ-
ual's exposure to hypothesized risk factors
(i.e., the biologically relevant dose [Thomas
and Hatch, this issue]). This task is made
very difficult by the lack of information
about environmental sources of emission,
the complex pattern of most long-term
exposures, the individual's ignorance ofpre-
vious opportunities for exposure, the lack of
good biological indicators ofexposure level,
and the lack ofsufficient resources to collect
individual exposure data on large popula-
tions. The consequences of exposure mis-
measurement are probable bias in the
estimation of effect (see "Sources of
Epidemiologic Bias") and possible loss ofpre-
cision and power with which effects are esti-
mated and tested (23,24). Theproblem and
issues ofexposure measurement are discussed
more thoroughly by Hatch and Thomas in
this issue.
Rare Diseases, Low-Level Exposures,
and Small Effects. In most epidemiologic
studies ofenvironmental hazards, statistical
objectives may be further compromised by
the infrequent occurrence ofthe disease or
outcome ofinterest, by the low prevalence
or levels ofenvironmental exposures in the
general population, and by the search for
small effects (forwhich the true rate ratio is
between 0.5 and 2). A critical consequence
of these features is usually substantial loss
of precision and power with which effects
are estimated and tested. In addition, it
becomes more difficult for the investigator
to separate the effect of the exposure of
interest from the distorting effects ofextra-
neous factors. Causal inference can then
be seriously compromised.
Research Objectives and
Strategies
Given the above problems, epidemiologists
mustcarefilly plan theirstudies, analyze their
data, and interpret their findings. Inaccurate
results reflect both random errors ofestima-
tion (chance) and systematic errors or bias.
An epidemiologically unbiased or valid esti-
mate of a causal parameter is one that is
expected to represent perfectly (aside from
chance) the truevalue ofthe parameter in the
basepopulation.
Source ofEpidemiologicBias
A common framework for describing the
validity ofepidemiologic research is to con-
sider three sources ofbias in the estimation
of effect: selection bias, information bias,
and confounding (2). Despite the practi-
cal attractiveness of this framework, the
three types ofbias are not entirely separate
concepts. The amount ofconfounding, for
example, can depend on how subjects are
selected.
Selection Bias. Selection bias means
that the way in which subjects are selected
into the study population or into the analy-
sis (due to lost subjects or missing data)
distorts the effect estimate. In general, this
problem occurs when either disease status
or exposure status influences the selection
of subjects to a different extent in the
groups being compared. Selection bias is
mostlikelyto beproblematicwhen theinvesti-
gator does not identify the base population
from which studycases arose.
Information Bias. Information bias
means that the nature or quality ofmeasure-
ment or data collection distorts the effect
estimate. The primary source of informa-
tion bias is error in measuring one or more
variables. When exposure status or disease
status is misclassified, bias usually occurs. If
the probabilities ofmisclassification ofeach
variable are the same foreach categoryofthe
other variable (nondifferential misclassifica-
tion) and ifthe errors for different variables
are independent, the estimate of effect is
usually biased toward the null value (indi-
cating no effect). Possible exceptions to this
principle ofnondifferential misclassification
leading to conservative effect estimates arise
when the misclassified exposure variable is
categorized into more than two groups
(25). In other situations involving differ-
ential misclassification (unequal misclassifi-
cation probabilities) or correlated
measurement errors, the effect estimate
may be biased in either direction. In many
studies, therefore, the magnitude of mis-
classification bias is difficult to predict,
especiallywhen other biases are operating.
Confounding. Confounding refers to a
lack of comparability between exposure
groups (e.g., exposed versus unexposed)
such that disease risk would be different
even if the exposure were absent or the
same in both populations (16). Thus,
confounding is epidemiologic bias in the
estimation of a causal parameter (see
"Population Parameters"). Because there is
no empirical method for directly observing
the presence or magnitude ofconfounding,
in practice we attempt to identify and con-
trol for manifestations of confounding.
This is done by searching for differences
between exposure groups in the distribu-
tion of extraneous risk factors for the dis-
ease, which are called confounders. Thus,
a confounder is a risk factor (or proxy) that
is associated with exposure status in the
base population. A covariate meeting these
criteria is not a confounder, however, ifits
associationwiththeexposure isdueentirely to
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the effect ofthe exposure on the covariate;
for example, the covariate might be an
intermediate variable in the causal pathway
between the exposure and disease. If the
exposure and covariate are time-dependent
variables, it is possible for that covariate to
be both a confounder and an intermediate
variable (see "Cohort Study").
TheNeedforCovariateData
In addition to the exposure of interest,
there is the need in virtually all epidemio-
logic studies to collect data on other known
or possible risk factors for the disease.
These covariates may be relevant to the
exposure effect in three ways: a) as con-
founders, b) as intermediate variables, and
c) as effect modifiers.
The effects of confounders must be
controlled or removed analytically to
obtain unbiased estimates of causal para-
meters. This control is usually achieved
through stratification or model fitting.
The assessment and control ofintermediate
variables can elucidate causal mechanisms
that explain exposure effects (26). This
approach often leads to new etiologic
hypotheses and new intervention strategies
for disease prevention.
When the exposure-effect measure
varies across categories or levels of another
factor, we call the second factor an effect
modifier; this statistical phenomenon is
called effect modification or an interaction
effect. The assessment of effect modifica-
tion is model-dependent, meaning that it
depends on what (causal) parameter is used
to measure the effect (2-6). For example,
an extraneous risk factor that does not
modify the risk ratio for the exposure will
modify the risk difference. The assessment
of effect modification is important for
properly specifying the predictors in statis-
tical models (2,14), for making inferences
about possible biological (causal) interac-
tions between exposures (e.g., synergy) (5),
and for generalizing one's results to other
populations (see "Cohort Study").
TypesofRmech
Therearethreegeneraldesignstrategiesforcon-
ductng population research: a) experiments in
which the investigators randomly assign (ran-
domize) subjects to two or more treatment
(exposure) groups; b) quasi-experiments in
which the investigators make the assignments
to treatment groups nonrandomly; and c)
observational studies in which the investiga-
tors simplyobserve exposure (treatment) sta-
tus in subjects without assignment (2).
Although some epidemiologists dassify the
first two types as intervention studies, obser-
vational studies mightalso involvetheevaluation
ofan intervention thatwas not implemented or
controlledbytheinvestgators. Social scientists
often use the term quasi-experiment to mean
anytypeofnonrandomizedstudy(27).
Experiments. In a simple experiment,
there are usually two treatment groups.
One group is assigned to receive the new
experimental intervention and the other
(control) group is assigned to receive no
intervention, a sham intervention (placebo),
or another available intervention. Simple
randomization of individuals to treatment
groups implies that all possible allocation
schemes of assigned subjects are equally
likely (28). Following randomization, the
investigator follows subjects for subsequent
disease occurrence or change in outcome sta-
tus. A comparison ofrisks between treatment
groups provides an estimate of a causal
parameterreflectingthetreatmenteffect.
Because experiments are best suited eth-
ically and practically to the study ofhealth
benefits, not hazards, experiments in envi-
ronmental epidemiology would usually be
limited to the study ofpreventive interven-
tions. Furthermore, it is generally impossi-
ble or infeasible to randomize subjects
individually. The only practical alternative,
therefore, is to randomize by group, where
the group might be a city, school, work site,
etc. (29). The major limitation of group
randomization is somewithin-group depen-
dence (correlation) ofthe outcome variable,
which reduces precision and power (30,31).
Thus, the effective sample size falls between
the number of randomized groups and the
total number of subjects (see Prentice and
Thomas, this issue).
As an example, consider the hypothesis
that the intake offluoride ions in drinking
water has a protective effect on the occur-
rence of dental caries in children. An
experiment might be conducted by ran-
domly assigning many water districts (each
with one fluoride-deficient water supply
without treatment) either to implement
sodium fluoride treatment under the con-
trol of the investigators or to continue its
current policyofno treatment for the dura-
tion offollow-up. Assuming the hypothe-
siswere true, wewouldexpect thesubsequent
incidence rate of dental caries to be lower
in the treated districts than in the untreated
districts.
Randomization insures a valid compari-
son ofsubjects according to intended treat-
ment, i.e., assigned treatment, but not
according to treatment actually received
(16;28). That is, randomization ofa suffi-
cient number of units (subjects or groups)
provides some assurance that the assigned
treatment groups are comparable with
respect to inherent risk. This does not imply
that there can be no confounding in a com-
parison ofrandomly assigned groups. Even
with perfect adherence to treatment assign-
ments and no loss to follow-up, assigned
groups might have, by chance, different
hypothetical risks in the absence of treat-
ment. Nevertheless, such confounding, ifit
exists, is equally likely to be positive or nega-
tive; conventional confidence-interval esti-
mates and p values reflect the possibility of
this bias, which becomes smaller as the
(effective) sample size increases (28). This
protection against confounding afforded by
randomization, however, does not apply to
lack ofadherence or loss to follow-up, both
ofwhich usually do not occur randomly.
Furthermore, if some subjects cross over
between treatments (e.g., residents ofa fluo-
ridated district obtain their water from non-
fluoridated districts), a comparison of
assigned groups will underestimate the true
treatment effect evenwhen the crossover is ran-
dom (32). A comparison ofcompliers with
noncompliers, on the other hand, is essentially
observationalandthereforepronetobias.
Qwsi-ExpeHments. A quasi-experiment
may be done similarly to an experiment by
comparing two or more nonrandomized
groups, oritmaybedonebycomparing oneor
more groups over time, before versus after the
intervention is initiated in at least one
group. With the latter approach, the com-
position of each group may change over
time so that subjects observed before the
intervention are not the same subjects
observed after the intervention.
Returning to the fluoride hypothesis, a
quasi-experiment was done in the 1940s
and 1950s by comparing two similar,
nearby cities in New York State, both of
which lacked fluoride treatment before
1945. Newburgh started sodium fluoride
treatment in 1945 and continued through-
out the 10-yr postintervention follow-up
period; Kingston continued to use its fluo-
ride-deficient water without treatment
(33). The investigators found that the rate
ofdecayed, missing, or filled (DMF) teeth
in children, ages 6 to 12, decreased by
almost 50% in Newburgh but increased
slightly in Kingston.
Because subjects were not individually
randomized in this study, it is possible that
children in the treated group differed from
children in the comparison group with
respect to other risk factors for tooth decay,
such as diet. Thus, the investigators' com-
parisons might have been confounded.
Note, however, that randomization by city
would not have reduced this possible bias
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in the Newburgh-Kingston study, because
the two assigned treatment groups would
be equally noncomparable regardless of
which citywas assigned fluoride treatment.
Observational Studies. Unlike experi-
ments and quasi-experiments, observational
studies are commonly used to estimate the
effects ofexposures hypothesized to beharm-
ful, fixed attributes (e.g., race and genotype),
characteristics, behaviors or exposures over
which the investigator has little or no control
(e.g., weight, depression, and sunlight expo-
sure), and other exposures for which manip-
ulation or randomization would be unethical
or infeasible. Observational studies are often
conducted with secondary or retrospective
data (instead of primary prospective data)
and/or without following individual subjects
for change in disease status. For example,
the fluoride hypothesis could be tested by
comparing the prevalence ofdecayed, miss-
ing, or filled teeth in children who live in
areas supplied by fluoridated water with the
corresponding prevalence in children who
live in areas supplied by nonfluoridated
water. Although such a study would be less
expensive and easier to conduct than would
the previous examples, there are additional
methodologic problems that could lead to
bias ormisinterpretations.
The remainder ofthis artide is devoted
to an elaboration of observational study
designs. In "Basic Observational Designs,"
we cover the basic designs in which data on
disease status, exposure status, and all
covariates are collected at the individual
level; that is, the unit ofanalysis is the indi-
vidual (or body part, such as the tooth or
eye). In "Ecological Designs," we cover
designs in which the unit of analysis is a
group ofindividuals, such that information
is missing on the joint distributions ofkey
variables at the individual level.
Basic Observational Designs
Frequently, hypotheses about environmen-
tal risk factors for disease are derived from
animal studies, dinical observations, reports
ofdisease clusters, descriptive findings from
population surveillance systems, and various
types ofexploratory studies (e.g., case series,
mapping studies, and migrant studies).
Formal testing of these hypotheses most
often proceeds by conducting observational
studies ofthe types described in this section.
Basicdesigns in epidemiology maybeclas-
sified according to two dimensions: type of
studypopulation andtypeofsamplingscheme
(34). First, the studypopulation islongitudi-
nal, involving the detection ofincident events
during a follow-up period; or it is cross-sec-
tional, involving the detection ofprevalent
cases at one time. Second, the sampling strat-
egy involves complete selection ofthe entire
population from which study cases are identi-
fied, or it involves incomplete or case-control
sampling ofa fraction (<100%) ofthe non-
cases in thepopulation fromwhichstudycases
are identified. Case-control sampling, there-
fore, implies stratification on disease status in
the selection process. Combining these two
dimensions results infourbasicdesigns: longi-
tudinal studies of a complete population
(cohort studies); cross-sectional studies ofa
complete population (cross-sectional studies);
longitudinal studies with case-control sam-
pling (case-controlstudieswith incidentcases);
and cross-sectional studies with case-control
sampling (case-control studies with prevalent
cases). In addition to these basic designs, we
also discuss newdevelopments in genetic stud-
ies forassessinggene-environment mteractions
(see"GeneticStudies").
CohortStudy
A cohort or follow-up study is a longitudi-
nal design of a specified population in
which exposure status is measured for all
subjects at the start offollow-up (baseline)
and possibly during follow-up. The entire
study population-typically persons who
are free of the index disease at baseline-
are followed for detection of all incident
cases or deaths of interest. Thus, the base
population in this design is identical to the
studypopulation.
Cohort studies may be entirely prospec-
tive, meaning exposure status and disease
occurrence are ascertained for the period
during which the study is conducted, or
they may be entirely retrospective (histori-
cal), meaning exposure status and disease
occurrence are ascertained for a period
before the study begins. Retrospective data
are usually obtained from the subject's
recall of past events or from abstracted
records. Many cohort studies combine
both data-collection procedures; e.g., the
follow-up period for detecting the disease
starts before the study and continues
throughout the study period. Although
retrospective studies are generally much less
expensive and time-consuming, prospective
studies can be designed to collect more
appropriate, complete, and accurate data.
Example. Suppose we want to estimate
the possible effect of prenatal exposure to
passive smoke (not maternal smoking) on
the risk oflower respiratory disease during
the first 3 years oflife. We might identify
a large group of nonsmoking pregnant
women and interview them just before
delivery about their exposure to passive
smoke during pregnancy and about other
risk factors for the disease. The assessment
of passive smoking would involve measur-
ing exposure at home, work, and elsewhere
with an attempt to quantify the number of
smokers, cigarettes, and/or exposure time
for each woman by trimester. Then each
neonate would be followed by periodic
examinations and parental reports ofsymp-
toms to his or her third birthday. Byestab-
lishingastandard setofcriteriafordiagnosing
new cases of lower respiratory disease and
by categorizing the passive-smoke exposure
into two or more categories, we can com-
pare the 3-year risk of disease by exposure
group. In this hypothetical example, the
experience ofeach subject contributes to a
single exposure group. Since subjects are
not randomized to exposure groups, it is
important to control analytically for other
risk factors that are associated with expo-
sure status in the study (base) population.
For example, we might want to control for
the child's exposure to passive smoke at
home; if other family members smoked
during the mother's pregnancy, they are
also likely to have smoked during the
child's first 3 years of life. On the other
hand, we should probably not control for
birth weight even ifit is a risk factor for the
disease, because prenatal smoking affects birth
weight. Thus, provided low birth weight is a
risk factor for lower respiratory disease during
the first three years oflife, low birth weight is
likely to be an intermediate variable in the
causal pathway between prenatal exposure to
passivesmokeandthedisease.
Strengths ofa Cohort Design. The
prospective cohort study is the observa-
tional design that is most similar to an
experiment. The major strengths of this
design derive from the fact that disease
occurs and is detected after subjects are
selected and after exposure status is mea-
sured. Thus, we can usually be confident
that the exposure preceded the disease (i.e.,
there is no temporal ambiguity). This fea-
ture is particularly important when disease
can also influence exposure status (e.g.,
persons with asthma moving to drier, less-
polluted areas). Well-designed retrospec-
tive cohort studies also lack temporal
ambiguity ofcause and effect.
Another major strength of the cohort
design is the usual lack of selection bias
that threatens other basic designs (2).
Disease status cannot, in principle, influ-
ence the selection of subjects except, per-
haps, in poorly designed retrospective
cohort studies. Sometimes researchers,
ignoring this principle, propose random
sampling to reduce bias. In fact, random
sampling in a cohort study, unlike random
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assignment, does not prevent or necessarily
reduce epidemiologic bias in effect estima-
tion; i.e., random sampling generally does
not improve comparability between expo-
sure groups. It does, however, make the
study population representative of a larger
,well-defined source population (sampling
frame), which may make one's findings
more generalizable. For example, suppose
we initiated a prospective cohort study of
lung cancer by mailing questionnaires to a
random sample of 500,000 adults living in
a given region served by population cancer
registries. The questionnaire would request
information on previous cancer diagnoses,
exposure variables, and other risk factors
for lung cancer. Following responses by
100,000 selected residents, the cancer reg-
istries would be used to identify all new
cases of lung cancer diagnosed among
respondents during the subsequent 5 years.
Even though the 100,000 respondents will
differ in manyways from the 400,000 non-
respondents, these differences will not
cause epidemiologic bias in effect estima-
tion. Nevertheless, the exposure effect
observed for respondents (the base popula-
tion) may not be generalizable to the popu-
lation of nonrespondents. One possible
reason for this lack of generalizability is
that respondents and nonrespondents differ
on the joint distribution of one or more
effect modifiers.
As we will see in the next two sections,
the same level of nonresponse in a cross-
sectional or case-control study that we
assumed in the above cohort example
might seriously threaten the validity of
effect estimation. Thus, unlike cohort (or
randomized) studies, nonresponse in other
basic designs can easily introduce selection
bias because study cases have already
occurred when subjects are selected. As
noted in "Sources of Epidemiologic Bias,"
selection bias is most likely to be problem-
aticwhen the investigator does notidentifythe
base population from which study cases arose
(as in cross-sectional studies and certain
case-controlstudies).
Weaknesses ofa Cohort Design. A
potential weakness ofcohort designs is the
loss of subjects to follow-up due to death
from other diseases, lack of participation,
or migration. Unlike subject selection, loss
to follow-up can easily bias effect estima-
tion if attrition is associated with disease
risk to a different extent for exposed and
unexposed groups (2,35). Unfortunately,
we can neither rule out nor confirm such
bias by comparing lost subjects and fol-
lowed subjects with respect to baseline
characteristics (including risk factors) (35).
At best, baseline similarities between lost and
followed subjects only suggest that loss to fol-
low-up is probably not a major threat to
validity, especiallyiftheattritionrateislow.
Perhaps the major practical limitation of
a cohort design, especially prospective stud-
ies, is its inefficiency for studying rare out-
come events, which is what most diseases are
in nonclinical populations. Because expo-
sure status and other covariates must be
observed at the start of follow-up in the
entire studypopulation, a rare diseasewould
mean that most subjects will remain non-
cases. Comparing a small number of cases
with a large number of noncases is statisti-
cally and economically inefficient because of
the diminishing marginal return from addi-
tional noncases. Assuming a fixed sample
size, therefore, it is more efficient to study a
diseasewith an expected riskof30% than to
study a disease with an expected risk of 1%;
the former will result in more precision and
power for estimating and testing the expo-
sure effect. Moreover, substantial increases
in the sample size to compensate for too few
expected cases is often impractical or impos-
sible, especially when the size ofthe exposed
population available forstudyis limited.
Time-Dependent Exposures. In conven-
tional analyses ofcohort-study data, exposure
status and other covariates are usually treated
as fixed variables measured at baseline. Yet
the instantaneous and cumulative level of
most environmental exposures changes during
the follow-up period. Consequently, the
greater the change and the longer the follow-
up, the less appropriate are conventional
methods ofanalysis. A common solution to
this problem is to measure average exposure,
duration ofexposure, or cumulative exposure
before and during the follow-up period; then
thesevariables areanalyzedlikethesimple base-
lineexposurevariable, aspossible (fixed) predic-
tors ofdisease occurrence. Unfortunately, this
approach also has methodologic problems:
a) ifthefollow-up period fordetectingdisease
overlaps the period during which exposure
change is measured, the temporal relationship
ofan exposure-disease association is ambigu-
ous. We may not know whether exposure
changesprecededdisease occurrence ordisease
preceded changes in exposure level. b) Ifthe
levels of exposure and/or other risk factors
change overtime, theassociations betweenthe
exposure and these covariates also canchange;
then the amount ofconfounding ofthe esti-
mated exposure effect will change. The ana-
lytic method described above, therefore, will
not, in general, eliminate confounding due to
these risk factors (even when there is no mis-
dassification). c) When an extraneous risk
factoraffectssubsequentexposure status and is
affected by previous exposure status, that risk
factor can be a confounder and an intermedi-
ate variable simultaneously (36,37). For
example, suppose we want to estimate the
effect ofexposure duration on mortality from
a specific disease. Ifearly symptoms of the
disease lead to termination ofexposure, then
early symptoms, which is a risk factor for dis-
ease mortality, is both a confounder and an
intermediate variable ofthe exposure-disease
relationship. Consequently, standard meth-
ods ofanalysis will generally lead to a biased
estimate oftheexposureeffect, whetheror not
oneadjustsfortheriskfactor.
A statistical solution to the above prob-
lems was recently developed by Robins
(36,37) who treats the prolonged or chang-
ing predictor variables as time-dependent
covariates for which repeated observations
are collected during the follow-up. The
method involves estimating causal parame-
ters for hypothetical exposure experiences of
the studypopulation (15). For example, we
might want to compare the outcome risk for
all subjects had they remained exposed
throughout follow-up with these subjects
had they remained unexposed, controlling
for confounders at the start ofeach interval
(timestratum).
Cros-Secton Study
A cross-sectional design involves a single
ascertainment of disease prevalence in a
study population that is usually sampled
randomly from a single source population.
In this sense, the source population is that
larger group of individuals who are desig-
nated by the investigator as being eligible
for inclusion in the study. Generally, in a
cross-sectional study, we do not know how
long prevalent (existing) cases have had the
disease, nor can we identify the base popu-
lation (at risk) from which the study cases
arose. Exposure data on time-dependent
variables are usually measured retrospec-
tivelyto allowforexpectedvariations in disease
latency (before detection) and duration of
expression (afterdetection).
The statistical analysis ofcross-sectional
data typically resembles the analysis of
cohort or case-control data. Instead of
comparing disease risks for exposed and
unexposed groups, we compare disease
prevalences (P), as in a cohort study, or we
compare the prevalence odds (P/(1-P)), as
in a case-control study (see "Case-Control
Study"). Undercertainconditionsorassump-
tions, the prevalence ratio or prevalence
odds ratio is approximately equal to the
ratio of incidence rates or risks (i.e., the
causal parameter of interest) (2,38). For
example, disease prevalence in a population
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is a function of both incidence and the
duration of disease. If the mean duration
ofdisease (from onset to recovery or death)
is known to be identical for exposed and
unexposed cases, we can be more confident
that the prevalence odds ratio approximates
the incidence rate ratio.
Example. Suppose we want to estimate
the possible effect of prenatal exposure to
passive smoke (as in "Cohort Study") on
birth weight, categorized for convenience
into low (<2500 g) and normal. We iden-
tify all live births delivered in one hospital
during a given period (the source popula-
tion); then we take a random or quasi-ran-
dom sample (e.g., every third birth). By
obtaining exposure data retrospectively
from mothers near the time ofdelivery, we
can compare the prevalence of low birth
weight for infants prenatally exposed and
unexposed to passive smoke, controlling
analytically for confounders (e.g., maternal
age, maternal smoking, and prenatal care).
Even though births may be regarded as
incident events, the infant'sweight at birth is a
prevalence measure, because we do not know
the size ofthe base population. The causal
parameterofinterest isahypothetical compari-
son ofretarded development between fetuses
exposed topassivesmokeandthosefetuseshad
they not been exposed. Not only can we not
observe this hypothetical condition ofexposed
fetuses being unexposed, but we do not (or
cannot) follow the base population; the preva-
lence oflow birth weight is simply the end
resultofthathypotheticalfollow-up.
Strengths ofa Cross-Sectional Design.
Because there is no follow-up, cross-sectional
studies are less time-consuming and costly
than prospective cohort studies. It is also fea-
sible to examine many exposures and diseases
in the same study, which makes this design
useful for screening newhypotheses. In addi-
tion to causal inference, cross-sectional stud-
ies are important descriptively in health
administration, planning, and policy analysis;
information on disease prevalence is often
required to assess the need and demand for
health services and to evaluate intervention
programs in specifictargetpopulations (2).
Weaknesses ofa Cross-Sectional Design.
A major methodologic limitation of many
cross-sectional studies for making causal
inferences is temporal ambiguity of cause
and effect. Because we usually do not know
the duration ofthe disease in prevalent cases
and because exposure status is measured at
the same time as disease status, often we
cannot determine that exposure (or a certain
accumulation of exposure) preceded disease
occurrence. One approach for minimizing
this problem is to collect retrospective expo-
sure data and information on previous med-
ical diagnoses and the onset of symptoms
associated with the disease under study.
Not only may this approach be very unin-
formative for temporally linking exposure
and disease, but it is also likely to worsen
another potential problem, measurement
error. Reliance on retrospecive dataincreases
the likelihood and magnitude of measure-
ment errors, which generally leads to infor-
mation bias. Furthermore, because all data
are collected after disease has occurred, it is
very possible for the error in measuring one
variable to be related to the other variable
(differential misclassification) or to error in
measuring the other variable (correlated
errors). Such possibilities are particularly
likely in survey research and make potential
information bias severe andunpredictable.
When cross-sectional studies are con-
ducted without random sampling, they
offer little opportunity for making statisti-
cal inferences about descriptive, popula-
tion-specific parameters, e.g., the prevalence
ofa disease in a specified source population
(28). The lack of random sampling may
also worsen the potential problem ofselec-
tion bias in effect estimation, which would
be difficult to rule out a priori or to correct
in the analysis. Even with random sam-
pling, however, disease status or exposure
status can influence the selection of sub-
jects differentially by category of the other
variable. For example, exposed cases may
be less likely than others to be selected for
study, perhaps because new exposed cases
are less likely to survive than new unex-
posed cases (i.e., selective survival) or
because exposed cases are less likely to enter
the specified source population such as a
hospital (i.e., Berkson's bias) (2). Similarly,
selection bias can result from the differen-
tial participation of selected subjects (i.e.,
response bias).
Case-Control Study
Case-control studies are distinguished from
other basic designs by their sampling strat-
egy: The investigator selects only a fraction
of noncases (controls) from the population
from which the cases were identified
(2,3,5,34,39). Sometimes this population is
not the true (primary) base population (out
of necessity or convenience), and occasion-
ally controls are assembled without regard
for the identification of cases. The design
may be longitudinal, involving incident
cases, or cross-sectional, involving prevalent
cases. In both types, the investigator estab-
lishes the ratio of controls to cases, which
does not depend directly on the frequency
ofdisease in the population. As in cross-sec-
tional studies, exposure data on time-
dependent variables are generally measured
retrospectively to account forexpected varia-
tions in diseaselatency.
Estimation ofEffect. Unless the crude
disease rate or the size of the base popula-
tion is known, we cannot estimate the risk
or rate of the disease in the exposed and
unexposed populations. Nevertheless, we
can estimate the effect of the exposure on
disease by calculating the exposure odds
ratio, which computationally is similar to
the prevalence odds ratio in a cross-sec-
tional study (2,3,19,20). For this estima-
tion of effect to be valid, however, the
controls must be representative ofthe base
population that gave rise to the study cases.
In this context, representative means hav-
ing a similar distribution on other disease
risk factors and indicators ofdisease detec-
tion. The best method for making the con-
trols representative in this way is to sample
them randomly (with or without matching)
fromthebasepopulation (seebelow).
Matching. As in any observational
study, the investigator should control ana-
lytically for confounders by stratification or
model fitting. Intuitively, it would appear
that one method for achieving this control
is to match controls to cases on extraneous
risk factors (i.e., making controls similar to
cases on the joint distribution ofthese risk
factors). In a case-control study, however,
it is not the matching alone that controls
for theconfounding effects ofthematching
variables; rather, stratification in the analy-
sis eliminates this bias (1-6). In fact, the
net effect ofmatching in case-control stud-
ies (but not in cohort studies) is to intro-
duce selection bias that must be controlled
in the analysis. Thus, if the matching is
ignored in the analysis, the effect estimate
will usuallybe biased (2,4,14).
The potential advantage ofmatching in
the selection ofsubjects is that it allows the
investigator to control for confounders
more efficiently than if matching is not
used (1-6). Yet, in this regard, matching
can be counterproductive ifone matches in
a case-control study on strong correlates of
exposure in the base population that are
not risk factors (or proxy risk factors) for
the disease. This type of overmatching
results in a decrease in statistical efficiency
(i.e., less precision for a given number of
cases and controls) (1-6). The conditions
for overmatching, however, are very differ-
ent in cohort studies in which unexposed
subjects are matched to exposed subjects
(40). Matching can also be economically
counterproductive for achieving a certain
minimal precision ifit costs more to match
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than to increase the sample size without
matching (41).
Population-Based Case-Control Study.
In a population-based or hybrid case-con-
trol study, controls (noncases) are sampled
directly from the base population that gave
rise to the cases (39,42). When this design
involves the follow-up of a large dynamic
population, such as residents ofa state, iden-
tification of new cases is usually based on
data collected through a population registry.
The validity ofeffect estimation depends on
the completeness and accuracy ofcase ascer-
tainment and on careful description of the
base population. When the design involves
the follow-up of individuals in a fixed
cohort (e.g., as a part of a clinical trial or
cohort study), identification of new cases is
done byexams, interviews, or questionnaires
administered periodically to each individ-
ual in the cohort during the follow-up.
This latter strategy is npw called a nested
case-control study but also has been called a
synthetic case-control study (43).
There are three alternative methods for
selecdng controls in alongitudinal, population-
based case-control study a) In density sam-
pling, controls are selected longitudinally
throughout the follow-up. Typically, they
are individually matched to cases on time of
each case's diagnosis or identification and
possibly other factors; i.e., each control is
known to be at risk (disease-free) at the time
its matched case was first identified as dis-
eased. An advantage of time matching is
that exposure status is measured at about the
same time for all subjects in each matched
set (19). b) In cumulative sampling, all
controls are selected at the endofthe follow-
up period during which cases are identified.
Both cumulative- and density-sampling
methods can be used even when controls are
not selected directly from the base popula-
tion. c) In case-base or case-cohort sam-
pling, all controls are selected from the fixed
base population at the start ofthe follow-up
(42,44,45). An advantage ofthis method is
that one control group can be used to study
multiple diseases, provided that prevalent
cases ofeach disease are excluded from the
analyses involving that disease. In both
case-base and density sampling, it is possible
for a selected control to subsequently develop
thediseaseandbecomeacase inthestudy.
Example. Suppose we want to estimate
the possible effect of prenatal exposure to
passive smoke (as in previous examples) on
the risk of sudden infant death syndrome
(SIDS). Using hospital records and birth
certificate information, we identify a large
number of live births occurring in a given
region during a certain period. Then this
base population is followed prospectively,
using hospital records and/or a population
registry to identify all infant deaths. For
each diagnosed and confirmed case of
SIDS, we randomly select two live controls
matched to the case on age, race, and date
of the case's death; thus, controls are den-
sity sampled from the follow-up experience
(risk set) of the base population of live
births. As soon as possible after case detec-
tion, we interview the mothers of all sub-
jects to collect data on prenatal exposure to
passive smoke and other covariates.
Proportional (Case-Control) Study. A
proportional study is a special type of
case-control study in which selected con-
trols have developed or died from diseases
other than the index disease under study
(2). By definition, therefore, this is not a
population-based design, since controls
(especially deaths) may not be representa-
tive of the base population from which
study cases arose. In a proportional mor-
bidity study, both cases and controls are
selected from a dinical population such as
a hospital, clinic, physician's practice, or
screening program. Controls are selected
because they have other conditions or symp-
toms; thus, and they are likely to differ from
the base population ofcases in ways that affect
disease occurrence ordetection. This situation
will usually occur when the exposure is a risk
factor for those comparison diseases making
up the control group. Forexample, wewould
obtain a severely biased estimate ofthe smok-
ing effect in a hospital-based, case-control
study ifcontrols were selected from emphy-
sema patients because smoking is a strong risk
factorforemphysema.
Deaths comprise the entire population
of a proportional mortality ratio (PMR)
study. A group of deaths from the index
disease (cases) is compared with a group of
deaths from other diseases that might
include selected comparison disease(s) or
all other causes of death. Typically, all
study deaths are identified retrospectively
from the follow-up of a single population,
such as persons living in a certain region or
employed by a certain company during a
given period. Although study deaths are
incident events often identified from a
defined base population, the outcome vari-
able in this design is prevalence of disease
at death; we do not have the proper denomi-
nator to estimate the disease-specific mortality
rate in any (base) population. Furthermore,
exposure data are not obtained for the base
populationbutforstudydeathsonly.
In the conventional proportional mortal-
ity study, comparison deaths are all other
causes ofdeath occurring in the population.
The traditional method of analysis is to
compute the PMR, which is the proportion
of exposed deaths resulting from the index
disease divided by the proportion of unex-
posed deaths resulting from the index dis-
ease (6). Altematively, the data are analyzed
as in a case-control study, the researcher com-
putes the mortality odds ratio (46,47). An
important advantage of the alternative
approach is that the comparison (control)
group might be selected to indude only those
diseases thought to be unrelated to exposure
status. This design strategy, which also should
be used in a proportional morbidity study,
can help reduce selection bias by making
the comparison group more representative of
thebasepopulation. Anotheradvantageisthat
it allows use ofthe many analytic techniques
developedforcase-controlstudies (48,49).
Strengths ofa Case-Control Design.
The major advantage of the case-control
design over other basic designs is its effi-
ciency for studying rare diseases, especially
diseases with long latent periods. A greater
proportion of study costs for collecting
exposure and covariate data can be devoted
to cases rather than expending most available
resources on noncases. Thus, given a fixed
sample size, case-control sampling in a study
of a rare disease enhances the precision and
powerfor estimatingand testing the exposure
effect. In addition, some case-control stud-
ies, particularly proportional mortality
designs, tend to be relatively inexpensive
and feasible because they can be based on
readilyavailable data sources.
Weaknesses ofa Case-Control Design.
A key issue in the design of case-control
studies is the method and procedures for
selecting controls. Ideally, we would like
to make each study population-based, such
that every new case occurrence in a well-
defined base population is immediately
identified by the investigators and controls
are sampled randomly from the base popu-
lation. In practice, however, this goal is
not so easily accomplished, especially when
the base is a large, dynamic population that
cannot be examined periodically. Even
population surveillance and registry sys-
tems, when they exist, are likely to be very
incomplete for many diseases, such as
prostate cancer, Alzheimer's disease, and
ischemic heart disease. Ifexposed cases are
more likely or less likely to be detected or
reported than unexposed cases, the result-
ing effect estimate will be biased. In a
cohort study, this detection problem would
manifest as differential disease misclassifica-
tion bias; but in a case-control study, the
detection problem produces a form of
selection bias that might involve no disease
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misclassification in the total sample and,
therefore, cannot be corrected after subject
selection (50). To prevent such detection
bias, the investigator might select controls
who, purportedly, underwent the same
degree ofmedical surveillance as did study
cases (51) (e.g., persons screened for the
disease or patients treated for other related
conditions). Unfortunately, this approach
could introduce another problem by selecing
for the control group individuals with other
exposure-related conditions (see the discussion
ofproportional morbidity studies). The end
result might be, for example, to overcompen-
sate forpotential detection bias, producing net
bias in the opposite direction. In general, in
the absence ofperfect population-based meth-
ods, investigators mustselectcontrols to reflect
the expected magnitudes ofvarious potential
selectionproblems.
When there is relatively little variability
of exposure in the base population, we
expect imprecise estimation ofthe exposure
effect, even if the exposure is a strong risk
factor for the disease. Although such inef-
ficiency is usually quite apparent in cohort
studies, it may not be so apparent in
case-control studies, especially when the
investigator does not know the exposure
distribution in the base population. For
example, if environmental exposure levels
are high throughout the region ofthe base
population, a comparison ofcases and con-
trols would result in an unstable estimate
ofeffect and low power. As in cohort stud-
ies, the problem is not one ofbias. Limited
variability of exposure is likely to occur
when exposure status for individual sub-
jects is measured ecologically by assigning
to each subject the exposure level observed
for the area in which that subject lives or
works. Other problems accompanying
ecologic measurement are discussed in
"Ecologic Designs."
Two-Stage Designs. Just as cohort
studies are inefficient for studying rare dis-
eases, case-control studies are inefficient
for studying rare exposures. When both
disease and exposure are rare, therefore, any
basic design might require averylarge sam-
ple size to ensure adequate power. One
solution to this problem is a two-stage
design: stage 1 is a basic design in which
data are collected on exposure and disease
variables only; in stage 2, covariate data
and possibly more refined exposure data
(with less measurement error) are collected
on separate random samples of exposed
cases, exposed noncases, unexposed cases,
and unexposed noncases, all ofwhich are
identified from stage 1 results (52,53).
Sampling fractions for stage 2 are set larger
for those exposure-disease groups that con-
tain fewer subjects in stage 1. Thus, the
investigator can obtain approximately equal
numbers of the four exposure-disease
groups in stage 2. Stage 1 results are used
to estimate the crude (unadjusted) expo-
sure effect, and stage 2 results are used to
estimate the effect adjusted for covariates
and possibly a more refined exposure effect.
The analysis of stage 2 data considers the
sampling fractions (52-56). The two-
stage design is also advantageous when the
cost ofobtaining covariate data is large rel-
ative to the cost ofobtaining exposure and
disease data or when covariate data are
missing on a majorityofsubjects (52,54).
Case-Crossover Design. A standard
crossover design is an experiment or quasi-
experiment in which each subject receives
both the experimental and control treat-
ments at different times (i.e., each subject
serves as his or her own control) (57). Such
designs are seldom used in environmental
epidemiology because manipulation of
treatment status (with or without random-
ization) is usually unethical or infeasible
and because the outcome is usually a rare
event. Recently, Maclure (58) proposed an
observational analogue of the crossover
study called the case-crossover design,
which may be regarded as a special type of
pairwise-matched, case-control study.
This type ofdesign can be used to estimate
the possible transient effect ofa briefexpo-
sure (e.g., coffee drinking) on the subse-
quent occurrence of a rare acute-onset
disease (e.g., myocardial infarction) that is
hypothesized to occur within a short time
after exposure (i.e., during the effect
period). All subjects are newly detected
cases that serve as their own controls. That
is, for each case, the observed odds ofbeing
exposed during the effect period (e.g., one
hour before disease onset) is compared
with the expected odds of being exposed
during any random period of the same
duration (assuming no exposure effect).
The expected exposure odds is estimated
from the subject's report ofhis usual expo-
sure frequency before disease occurrence.
For example, ifa person drinks coffee twice
each day and the effect period is 1 hr, the
expected odds ofexposure during any 1-hr
period is 1/11. Thus, we would expect
that, for every 12 cases who drank coffee
twice each day, one case would have
occurred by chance within 1 hr of expo-
sure. Maclure recommends using standard
methods of matched analysis for person-
time (cohort) data to combine data from
all cases; however, this approach needs fur-
ther development to handle the temporal
autocorrelation of outcome status (i.e., a
case is either exposed during the effect
period orunexposed, but it cannot beboth).
Although the case-crossover design has not
yet been used to examine the possible
short-term effect of an environmental
exposure, this type ofstudy is feasible ifwe
can measure such exposures.
Gene6cStdy
The study ofvariation among individuals or
groups in their sensitivity to environmental
agents is one ofthe aims ofenvironmental
epidemiology. Such variation might be due
to differences in host characteristics, indud-
ing genetic factors, or to interactions with
other exposures. A complete survey of the
methods used to study the genetic determi-
nants ofdisease would be beyond the scope
ofthis report; instead, we will focus on the
approaches that might be used to address the
issueofgene-environment interactions.
Three basic types ofinformation might
shed light on the genetic component of
such interactions: a classification of the
subjects' genotypes at a major locus for dis-
ease susceptibility; some observable host
characteristic (phenotype) that is geneti-
cally determined and linked with the geno-
type that was responsible for sensitivity; or
family history as a surrogate for genetic (or
shared environmental) influences. The
choice of study design will depend upon
which ofthese is sought.
The first is the most powerful approach,
and its feasibility will grow as more and
more genes are identified and assays for
them become available. Ifthe genotype is
observable, it can be considered simply
another risk factor and any of the basic
design and analysis strategies used in epi-
demiology are applicable. For example,
Caporaso et al. (59) reported a case-control
study of lung cancer, in which the rate of
metabolism of the antihypertensive drug
debrizoquine was taken as a phenotypic
marker for a gene in the cytochrome P450
system that is responsible for metabolism of
carcinogens. It was shown that intermediate
and high metabolizers were at higher risk of
lungcanceroverall andthattherewas an inter-
action between metabolic rateandexposure to
occupationalcarcinogensandsmoking. Inthis
example, the genotype was not observed
direcdy but inferred from the phenotype, but
recent advances in molecular genetics, such as
the use ofrestriction fragment length poly-
morphism, are making direct observation
increasingly feasible.
Identifying host characteristics that
interact with environmental exposures can
be done in essentially the same way. A
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familiar example might be skin color as a
marker for sensitivity to sunlight in the
production ofmelanoma. No extensions of
standard epidemiologic methods would be
needed to address this question. The only
subtlety in this case arises when the gene
determining the host characteristic is not the
disease susceptibility locus but only linked
to it (i.e., nearby on the same chromosome).
A particular marker allele might be associ-
atedwith the disease in one familyand adif-
ferent allele in another family-, but in both
families, the marker and the disease would
be inherited together. This possibility
requires family data and the techniques of
linkage analysis. To date, such analyses have
been applied only to the study of genetic
effects without reference to the environmen-
tal covariates, but statistical techniques that
would assess such combined effects recendy
have become available (60).
Before trying to identify a specific major
gene that is related to sensitivity to environ-
mental exposures, one should assess whether
there is anyevidence that such sensitivity has
a genetic basis. This also requires collection
offamilydata, but unlike the standard analy-
ses aimed at examining the main effect of
genetics, one would also want to examine
interactions between familyhistory and envi-
ronmental exposures. Geneticists commonly
assemble a small number ofvery large pedi-
grees, sometimes selected to maximize the
chances that a major gene is operating in the
families, and subject them to segregation
analysis to study the mode of inheritance.
Again, these analyses seldom account for
environmental covariates and interactions,
although such methods are nowavailable. In
contrast, epidemiologists begin with a large
population-based series ofcases and controls
and restrict attention to the first- and some-
times second-degree family members. Their
analyses usually arelimited to asimplefamily
historycovariate (e.g., presence ofan affected
member, number ofaffected members, etc.)
in standard multivariate risk-factor models,
possibly but seldom including interactions
with environmental covariates. Susser and
Susser (61) have discussed two basic
approaches to such data: in the case-con-
trol approach, cases are comparedwith con-
trols in terms oftheirfamilyhistories; in the
cohort approach, the incidence ofdisease in
theexposed (case) families is comparedwith
the incidence in unexposed (control) fami-
lies. Either approach could easily be
extended to incorporate environmental
covariates and their interactions with fam-
ily history. The only difference is that the
cohort approach requires covariate data on
all of the family members, whereas the
case-control approach requires data only on
the originally sampled cases and controls.
Clearly, the cohort approach is more infor-
mative, but the conditions under which the
additional effort warrants the gain in infor-
mation about gene-environment interactions
have not been investigated.
The two major design issues to be
addressed in such studies are the method of
ascertainment offamilies and the informa-
tion to be collected on family members.
The former has been discussed at great
length in the genetics literature. The basic
problem is that if families are ascertained
through affected probands, families with mul-
tiple cases will tend to be overrepresented.
Therefore, various corrections for ascertain-
ment are applied in the standard methods
ofgenetic analysis. The relevance ofthese
approaches to the epidemiologic designs
for gene-environment interactions requires
further research. Often, only very limited
information is collected about family his-
tory in epidemiologic studies. The mini-
mal information should be an enumeration
of all affected family members together
with the sex and age ofeach family mem-
ber at risk; as discussed above, information
on major risk factors for all family mem-
bers at risk may also be desirable. Because
larger and older families are likely to have
more familial cases, the presence or num-
ber offamilial cases is not suitable as a fam-
ily history covariate. Moreover, expressing
the number affected as a proportion does
not solve the problem because multiple
cases in large families are more informative
than single cases in small families. A more
appropriate comparison is between the
observed number of familial cases and the
eqxcted number based on the person-time at
risk, in which the comparison is adjusted for
age,sex, andotherimportantriskfactors (62).
Ecologic Designs
An ecologic or aggregate study is one in
which exposure levels ofindividuals are not
linked to disease occurrence of those indi-
viduals. The net result is that the unit of
statistical analysis is usually the group, typi-
callypersons living in ageographic area such
as a census tract, county, or state. For each
group or region, therefore, we know the
average exposure level or distribution and
the disease rate, but we do not know the
joint distribution of these two variables.
Given adichotomous exposure, forexample,
wewould not know the numbers ofexposed
and unexposed cases in each group. Thus,
we cannot estimate the exposure effect
directly by comparing the disease rate for
exposedandunexposed populations.
Ecologic designs are therefore incom-
plete (2) in the sense that they lack certain
information ordinarily contained in the
basic designs. As noted in "Problems in
Environmental Epidemiology," the pri-
mary reason for this missing information in
environmental epidemiology is our inabil-
ity or lack of resources to accurately mea-
sure environmental exposures in large
numbers of individuals. Thus, the wide-
spread use of ecologic designs in environ-
mental epidemiology reflects a fundamental
problem of exposure measurement. In
addition, ecologic studies represent an
inexpensive design option for linking avail-
able data sets or record systems, even when
exposures are measured at the individual
level. The appeal ofthis alternative is that
aggregate summaries of many exposures,
induding sociodemographic and other census
variables, are often available for the same
regions that are used to summarizemorbidity
andmortalitydata.
With the inclusion of covariate data in
an ecologic study, the analysis may be only
partly ecologic. This condition occurs
when thejoint distribution oftwo or more,
but not all, variables is known within
groups. For example, suppose we want to
examine the possible effect of radon expo-
sure on lung cancer incidence, controlling
for age (the covariate). Although we might
know the age distribution of all new cases
and all persons at risk within each county
(from tumor registry and census data), we
would usually not know the within-county
association between radon exposure and
the other two variables. Sometimes data
sets like this are analyzed with the individ-
ual as the unit ofanalysis, where each indi-
vidual is assigned the average radon exposure
level that was measured for the region in
whichhe orshelives. Suchecologic measure-
ment ofexposure means that there is likely to
be substantial error in measuring the individ-
ual's exposure to radon, which could result in
informationbiasofeffectestimation.
TypesofEcologicStudies
Ecologic studies may be classified into five
design types that differ in several ways,
including methods ofsubject selection and
methods ofanalysis (2,63).
Exploratory Studies. In exploratory
ecologic studies, we compare the rate of
disease among many contiguous regions
during the same period, or we compare the
rate over time in one region. In neither
approach are exposures to specific environ-
mental factors measured (for individuals or
groups). The purpose is to search for spa-
tial or temporal patterns that might suggest
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an environmental etiology or more specific
etiologic hypotheses.
The simplest type of exploratory study
ofspatial patterns is agraphical comparison
ofrelative rates across all regions (i.e., map-
ping study), possibly accompanied by a sta-
tistical test for the null hypothesis of no
geographic clustering (64). In mapping
studies, however, a simple comparison of
estimated rates across regions is often com-
plicated by two statistical issues. First,
regions with smaller numbers of observed
cases show greater variability in the estimated
rate; thus, the most extreme rates tend to be
estimated for those regions with the fewest
cases. Second, nearby regions tend to have
moresimilar rates than do distant regions (i.e.,
positive autocorrelation). A statistical method
for dealing with both complications involves
empirical Baye' estimation of rates using an
autoregressive spatial model (65).
In certain exploratorystudies ofspatial pat-
terns, regions are characterized in terms of
general ecologic indicators such as degree of
urbanization (urban versus rural), degree of
industrialization (agricultural versus nonagri-
cultural), population density, socioeconomic
status, and ethnic diversity. The analysis of
these data usually involves comparisons of
regions grouped by one or more ecologic indi-
cators. This approach resembles the statistical
methods used in multiple-group studies (see
"Interpretation ofResults").
An exploratory ecologic study was con-
ducted by Mahoney et al. (66), who com-
pared age-standardized mortality ratios for
cancers, by sex, among all cities and towns
in New York State (exclusive ofNew York
City) between 1978 and 1982. By group-
ing these regions by quintile ofpopulation
density, they examined the associations
between density and deaths from all cancer
sites and selected sites, by sex. They found
linear associations between increasing pop-
ulation density and total cancer mortality
in both men and women. Because popula-
tion density may reflect various risk factors
for different cancers, the authors acknowl-
edge that their findings are consistent with
several alternative explanations.
An exploratory study of temporal pat-
terns is generally done by comparing dis-
ease rates for a geographically defined
population over a period of at least 20
years. A common statistical or graphical
approach for analyzing such longitudinal
data is cohort analysis (not to be confused
with the analysis of data from a cohort
study) (2). The objective ofthis approach
is to estimate the separate effects of three
time-related variables on disease occur-
rence: age, period (calendar time), and
birth cohort (year ofbirth). Because ofthe
linear dependency of these three variables,
there is an inherent statistical limitation
(identification problem) with the interpre-
tation ofcohort-analysis results. The prob-
lem is that each data set has alternative
explanations with respect to the combina-
tion ofage, period, and cohort effects. The
only way to decide which interpretation
should be accepted is to consider the find-
ings in light ofother (prior) knowledge of
the disease and its determinants.
A cohort analysis was conducted by Lee
et al. (67) on melanoma mortality among
white males living in the United States
between 1951 and 1975. They concluded
that the apparent increase in the melanoma
mortality rate during that period was due
primarily to a cohort effect. That is, per-
sons born in more recent years carried with
them throughout their lives a higher mor-
tality rate than did persons born earlier. In
a subsequent review paper, Lee (68) specu-
lates that the cohort effect might reflect the
impact of changes in a major risk factor
operating during youth, such as sunlight
exposure or burning.
Space-Time Cluster Study. Space-time
clustering refers to the interaction between
place and time of disease occurrence, such
that cases that occur dose in space also occur
dose in time (2). Evidence of space-time
clustering may suggest person-to-person
transmission of an infectious agent or the
effects ofpoint-source exposures, depending
on the disease and the cluster pattern. The
analytic search for space-time clusters
requires special statistical techniques that
may or may not incorporate information
on the base population and covariates
(69,70). Although the unit ofanalysis for
these methods is usually the individual,
space-time cluster studies are classified here
with ecologic designs because closeness in
space and time is a proxy measure for envi-
ronmental exposures-or at least the opportu-
nityforexpsr. Thus, useofplaceandtime
information is analogous to use ofspatial or
temporalindicators intheexploratorystudy.
Space-time duster analyses may be used
when members of a community perceive a
cluster or excess number of cases of one or
more diseases in their area. This activity is
often motivated by the suspicion that the
apparent duster is caused by a specific envi-
ronmental exposure, such as chemical waste,
pesticides, or electromagnetic fields. When
investigation begins, the first steps are tover-
ifythediagnoses ofall reported cases andiden-
tify any additional cases in the cluster area,
which must be defined. In addition to
space-time duster analyses, the investigators
will probably want to compare the disease rate
in the duster-area population with the rate in
another population thought to be unexposed
(retrospective cohort study), and they may
conductapopulation-basedcase-controlstudy
toidentifyriskfactors forthedisease.
Multiple-Group Study. In a multiple-
group ecologic study, we assess the ecologic
association between average exposure level
or prevalence and the rate ofdisease among
many groups or regions. This is the most
frequently used ecologic design in environ-
mental epidemiology. Studies are usually
conducted by linking separate sources of
data. For example, census and tumor-reg-
istry datamightbecombined to estimatecan-
cer rates for all counties in a state; other
state records or surveys might be used to
estimate average exposure levels by county.
Statistical methods for estimating exposure
effects in multiple-group studies are dis-
cussed in "Interpretation of Results" and
by Prentice and Thomas in this issue.
Hatch and Susser (71) conducted a mul-
tiple-group ecologic study to examine the
association between background gamma radi-
ation and childhood cancers between 1975
and 1985 in the region surrounding the
Three Mile Island nuclear plant. Using data
from a 1976 aerial survey, they estimated the
average radiation level for each of69 tracts in
thestudyregion. The results oftheiranalyses
showed a positive association between radia-
tionlevel and the incidence ofchildhood can-
cers. The authors were cautious in making
causal inferences, however, because the large
effect observed for solid tumors, as well as
leukemias, was notexpected.
Time-Trend Study. In time-trend (or
time-series) studies, we assess the ecologic
association between change in average expo-
sure level or prevalence and change in dis-
ease rate in one geographically defined
population. The assessment may be done
by simple graphical displays or by more for-
mal statistical techniques (72-75). With
either approach, however, the interpretation
of findings is often complicated by two
issues. First, changes in disease dassification
and diagnostic criteria can produce very
misleading results. Second, the latency of
the disease with respect to the exposure of
interest may be long, variable across cases,
and/or unknown to the investigator; thus,
employing an arbitrary or empirically
defined lag between the two trends can also
produceverymisleading results (76).
DarbyandDoll (77) comparedthetrends
ofaverage annual absorbed doses ofradiation
fallout from weapons testing and childhood
leukemia rates in three European countries
between 1945 and 1985. Although the
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leukemia rates varied over time in each coun-
try, they found no convincing evidence that
these changes were attributed to changes in
fallout radiation.
Mixed Study. The mixed ecologic
design combines the basic features of the
multiple-group study and the time-trend
study. The objective is to assess the eco-
logic association between change in average
exposure level or prevalence and change in
disease rate among many groups. Thus,
two types of comparisons are made simul-
taneously: change over time within groups
and differences among groups.
For example, Crawford et al. (78) eval-
uated the hypothesis that hard drinking
water (i.e., water containing more calcium
and magnesium ions) is a protective risk
factor for cardiovascular disease (CVD).
They compared the absolute change in
CVD mortality rate between 1948 and
1964, by age and sex, in 83 British towns.
The towns were divided into three groups:
a) five had experienced increases in water
hardness; b) six had experienced decreases,
and c) 72 had experienced little or no
change in water hardness. In all sex-age
groups, especially for men, the authors
found an inverse association between
trends in water hardness and CVD mortal-
ity. In middle-aged men, for example, the
increase in CVD mortality was less in
towns that made their water harder than in
towns that made their water softer.
InterpretaonofResults
Statistical analysis in a multiple-group study
usually involves fitting the data to a mathe-
matical model (see Prentice and Thomas,
this issue). The outcome variable is a func-
tion of the disease rate in each group; pre-
dictors indude the average exposure level or
proportion exposed in each group plus other
ecologic covariates, the effects ofwhich the
investigator wants to control. We show in
"Control for Covariates" that these covari-
ates need not be confounders (i.e., at the
individual levelwithin groups).
Results of the fitted model can be used
to estimate the exposure effect, i.e., the
same causal parameter we would like to
have estimated had the study been con-
ducted at the individual level (63,79,80).
For example, suppose the exposure variable
is the proportion exposed in each group
and there are no covariates. Assuming a
linear model, we can use weighted least-
squares regression to estimate the slope (b)
and intercept (a). The predicted disease
rate in a group that is entirely exposed is
then a + b(l) = a + b, and the predicted
rate in a group that is entirely unexposed is
a + b(O) = a; therefore, the estimated rate
ratio is (a + b)la = 1 + bla. It is important
to note that this estimation procedure
implies extrapolating the results of the
model to both extreme values ofthe expo-
sure variable, either or both ofwhich may
lie well beyond the observed range. It is
not surprising, therefore, that different model
forms can lead to very different estimates of
effect (81). Infact, certain modelassumptions
may lead to rate-ratio estimates that are
negativeandthusmeaningless.
EcologicBias
The use ofecologic data to estimate causal
parameters has a major methodologic limi-
tation, called the ecological fallacy (82),
aggregation bias (83), cross-level bias (84),
and ecologic bias (85,86). Ecologic bias
refers, in general, to the failure of ecologic
estimates of effect to reflect the true effect
at the individual level. Some of this bias
may occur in individual-level studies ofthe
same population, but some of it is due
specifically to the aggregation of subjects
into groups. More importantly, the magni-
tudeofecologic bias is likelyto be more severe
andlesspredictablethan is individual-level bias
in estimating the same effect (63,81,8687).
It isverypossible, forexample, thatanecologic
analysis ofa (true) positive risk factor would
produceanapparentlyprotective effect.
The underlying problem of ecologic
bias may be regarded as a special form of
information bias resulting from within-
group heterogeneity of exposure status,
which is not captured in the analysis. For
example, a positive linear relationship
between proportion exposed and disease
rate does not necessarily mean that exposed
individuals are at greater risk for the disease
than are unexposed individuals; rather,
unexposed individuals may be at greater
risk in groups containing proportionally
more exposed individuals. The implication
ofthis latter explanation is that an individ-
ual's group affiliation has an effect on dis-
ease occurrence that reflects more than just
the individual's exposure status.
A mathematical understanding of eco-
logic bias was first provided for correlation
coefficients by Robinson (88) and later
extended to regression coefficients by Duncan
et al. (89). Nevertheless, the conditions for
valid ecologic estimation and the relationship
between ecologic bias and other method-
ologic issues are still not well understood.
Because the results of ecologic analyses are
often used to influence policy decisions, as
well as to make causal inferences, it is
important for researchers to appreciate the
complexities ofecologicinference.
Sources ofEcologic Bias. Ecologic bias is
often confused with confounding, perhaps
because regional differences in disease rates
can be due to variation in the distribution of
extraneous risk factors across regions. To
darify the confusion between these two con-
cepts, Greenland andMorgenstem (86;87,90)
show that ecologic bias can arise from three
different sources.
Within-Group Confounding (At the
IndividualLevel). The exposure effect may
be confounded within groups (as described
for nonecologic studies in "Sources of
Epidemiologic Bias"). Thus, if the within-
group effect is equally confounded by the
same unmeasured risk factors in everygroup,
we can expect the ecologic estimate ofeffect
to be biased as well. In general, ecologic esti-
mates will be biased in this way if the net
within-group bias across groups (due to
uncontrolled confounders) is not zero. It is
possible, therefore, for positive confound-
ing in certain groups to cancel negative
confounding in othergroups.
The other two sources of ecologic bias
are unique to this design and can be under-
stood by considering group (or group affili-
ation) as a nominal predictor of disease
occurrence at the individual level.
Confounding by Group. Ecologic bias
can occur when the disease rate in the unex-
posed population varies across groups. Since
average exposure level also typically varies
across groups, group is a confounder of the
exposure effect at the individual level. This
set ofconditions may occur if one or more
unmeasured risk factors are differentially dis-
tributed across groups, even ifthese risk fac-
tors are unrelated to exposure status within
groups and, therefore, are not confounders at
the individual level.
EffectModification by Group. Ecologic
bias can also occur when the exposure
effect varies across groups, i.e., when group
modifies the effect of the exposure at the
individual level. This condition may result
from extraneous risk factors (effect modi-
fiers) being differentially distributed across
groups or by misspecification ofthe model
form used to analyze the data. Ecologic
bias of this type tends to be more severe
when there is little variability in average
exposure across groups (85), even when
the effect modification is relatively weak
and there is no confounding by group.
Taken together, the above principles
imply that there will be no ecologic bias if
the disease rate in the unexposed popula-
tion and the exposure effect do not vary
across groups and if there is no net con-
founding within groups. Unfortunately, it
is very unlikely that all ofthese conditions
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will be met in one ecologic study. Although
small departures from these conditions may
result in substantial bias (81,86), it is also
possible that there will be little or no bias
in certain studies when one or more of
these conditions are not met.
Ifevery group were completely exposed
or unexposed, there would be no ecologic
bias attributable to confounding or effect
modification bygroup. Indeed, ifall covari-
ates were measured at the individual level,
such a study would not be an ecologic
design. Thus, to reduce ecologic bias, we
should select regions that minimize within-
region exposure variation and maximize
between-region variation (63,81). One
strategy forachieving thesegoals is to choose
the smallest unit of analysis for which
required dataareavailable (e.g., census tracts
or blocks). Unfortunately, certain data are
seldom available at this level (e.g., personal
behaviors and biomedical factors), and there is
no guarantee that these smaller units are more
homogeneous with respect to exposure status.
Furthermore, use ofsmaller groups might
increase the problem ofmigration between
groups (see"OtherMethodologicProblems").
ContolforCovariat
In a study conducted entirely at the indi-
vidual level, an extraneous risk factor pro-
duces bias (confounding) in effect estimation
only if it is associated with exposure status
in the base population (see "Sources of
Epidemiologic Bias"). In a multiple-group
ecologic study, however, an extraneous risk
factor can produce ecologic bias even ifit is
not associated with exposure status within
regions (at the individual level) (86,87,90).
Such bias occurs typically because the eco-
logic association (across regions) between
the exposure and risk factor produces con-
founding and/or modification ofthe expo-
sure effect by group (see "Ecologic Bias").
Conversely, an extraneous risk factor that is a
confounder within regions may not produce
ecologic bias ifthe net within-group bias is
zero (see "Ecologic Bias") or ifthe risk factor
isecologicallyuncorrelatedwiththeexposure.
One method to control forextraneous risk
factors in ecologic studies is to indude predic-
tor terms for these risk factors in the model
(e.g., the proportion ofsmokers or the mean
familyincome ineachregion). Unfortunately,
evenwhen such covariate dataareavailable for
all regions, ecologicadjustment usuallycannot
beexpected to remove completelytheecologic
biasproducedbytheseriskfactors. Infact, itis
possible for such ecologic adjustment to
increasebias (86).
The general conditions under which
the ecologic control for extraneous risk fac-
tors either increases or decreases bias have
not been delineated. Yet, under certain
restrictive conditions, ecologic control for
covariates will produce unbiased estimates
of the exposure effect, provided there are
no other sources ofbias (e.g., outcome mis-
dassification). Ifthe effects ofthe exposure
and the covariate on disease rate are exactly
additive within every region (i.e., the rate
difference for each variable is constant
across levels ofthe othervariable) and ifthe
rate conditional on both predictors is
exactly the same in every region, ecologic
regression of disease rate on the mean
exposure and covariate levels (i.e., multiple
linear regression) will lead to unbiased esti-
mates ofboth effects (83,84). Underthese
conditions, group affiliation does not con-
found or modify the exposure effect at the
individual level. However, as shown by
Greenland (81), relatively minor deviations
from perfect additivity (linearity) can lead
to appreciable ecologic bias because eco-
logic rate ratios can be extremely sensitive
to the choice ofmodel form, in contrast to
individual-level estimates. Furthermore,
the two conditions noted above are only
sufficient for no ecologic bias to occur; eco-
logic bias may be absent when either or
both conditions are not met.
Richardson and Hemon (91) recently
pointed out that there is another set of
conditions for which ecologic control of
covariates is possible. If a) the exposure
and covariates are uncorrelated within
regions, b) their effects on disease are mul-
tiplicative (i.e., the rate ratio for each vari-
able is constant across levels of the other
variable), and c) the rate conditional on
both predictors is exactly the same in every
region, then ecologic bias due to the covari-
ates can be removed or largely reduced by
including product terms in the linear
model. Ofcourse, such conditions are very
difficult to verify in ecologic studies; ifthe
exposure and covariates (other riskfactors) are
correlatedwithinregions, thecovariateswill be
confounders at the individual level and sub-
stantial ecologic bias can occur even with
producttermsinthemodel (81).
When the data are not entirely ecologic
(see "Ecologic Designs"), rate standardiza-
tion is another method often employed to
adjust for extraneous risk factors in ecologic
studies. For example, ifthe age distribution
is known for cases and for the base popula-
tion in every region, we can mutually stan-
dardize the rate in every region to the age
distribution ofawell-defined (standard) pop-
ulation (5); then we use the standardized
rates as the outcome variable in the ecologic
analysis. Unfortunately, this method does
not always reduce ecologic bias due to the
variables forwhich the ratesarestandardized;
in fact, the result may be to increase bias
appreciably (8692). Standardization can be
expected to reduce ecologic bias only if all
variables in the model (i.e., disease and all
predictors) are mutually standardized for
those other confounders (e.g., age) not
included as predictors in the regression
model. Thismethodisoften notfeasible, for
example, when the investigator does not
know the age distribution of exposed and
unexposedpopulations within everyregion.
OtherMethodologicPrblems
In addition to ecologic bias and the related
difficulties of controlling for extraneous
risk factors, there are other methodologic
problems with ecologic analysis, a few of
which are addressed below.
Exposure Misclassification Bias. As
noted in "Sources of Epidemiologic Bias,"
nondifferential misclassification of expo-
sure status in individual-level studies nearly
always results in bias toward the null value;
e.g., the estimated rate ratio will be doser to
one than is the true rate ratio. In multiple-
group ecologic studies, however, this princi-
pledoes notholdwhen theexposurevariable
is formed from the aggregated observations
of all individuals in each region (e.g., the
proportion exposed). Brenner et al. (93)
have shown that nondifferential misdassifi-
cation of a binary exposure within groups
usually leads to overestimation of the rate
ratio (away from the null value) in ecologic
studies, which can be severe. This apparent
contradictionbetweenecologicandindividual-
level studies can be understood byconsidering
just two regions. Nondifferential exposure
misdassiflcation in both regions will produce
an estimated difference in exposure preva-
lence that is smaller than the true difference.
Consequently, the estimated regression
coefficient (slope) for the exposure variable
in a linear ecologic model will be overesti-
mated, leading to overestimation ofthe rate
ratio. Ltde is known about the impact in eco-
logicstudiesofwithin-grouperrorinmeasuring
continuousormultiple-categoryexposures.
ConfounderMisclasifiation. In stud-
ies conducted at the individual level, mis-
dasificaion ofaconfounder, ifnondifferential
with respect to exposure and disease, will
usually reduce our ability to control for the
confounder in the analysis (94,95). That
is, adjustment will not completely elimi-
nate the bias due to the confounder. In
ecologic studies, however, nondifferential
misclassification of a binary confounder
within groups does not affect our ability to
control for that confounder (96). Thus, sur-
Environmental Health Perspectives Supplements
Volume 101, Supplement4, December 1993
34STJDYDESIGN
prisingly, nondifferential milsdassification ofa
confounder is less problematic in ecologic
studies, providedthere is noecologicbias, than
inindividual-level studies.
Collinearity. It is probably more com-
mon in ecologic studies than in otherstudies
for two or more predictors to be highly cor-
related across groups (63,97,98). This issue
is particularly relevant with environmental
factors, such as the associations between lev-
els ofdifferent contaminants in air or drink-
ing water or associations between different
socioeconomic indicators. The implication
ofsuch collinearities is that it is very diffi-
cult, perhaps impossible, to separate these
effects statistically; analyses yield model
coefficients with very large variances and
often severelydistorted estimates ofeffect.
Temporal Ambiguity of Cause and
Effect. Use of incidence data in a cohort
study usually implies that disease occurrence
did not precede exposure to the hypothe-
sized risk factor. Yet, in multiple-group or
time-trend ecologic studies use ofincidence
data provides no such assurance against this
temporal ambiguity (63). This inferential
problem is most troublesomewhen it is pos-
sible for disease to influence exposure status
either at the individual level (see "Cohort
Study") or at the ecologic level (e.g., inter-
ventions designed to reduce exposure levels
in areas with high rates ofdisease).
The problem oftemporal ambiguity in
ecologic studies is further complicated by
an unknown or variable latent period
between exposure and disease occurrence.
The investigator can only attempt to deal
with this problem by establishing a specific
lag period between observations ofaverage
exposure and disease rate. Even when the
average latency is known, however, appro-
priate data may not be available to accom-
modate the desired lag.
Migration. Migration of individuals
into or out ofthe base population can cause
selection bias in any type ofepidemiologic
study, because migrants and nonmigrants
may differ on both exposure prevalence and
disease risk. Little is known about the mag-
nitude ofthis bias or how it can be reduced
in ecologic studies, especiallywhen studying
diseases with long latent periods. One
approach might be to use larger geographic
groups (e.g., states instead of counties as
units ofanalysis) (99). Unfortunately, this
approach is also likely to increase the poten-
tial for severe ecologic bias, because it
makes the groups less homogeneous with
respect to exposure (see "Ecologic Bias").
Another approach might be to incorporate
available data on the distributions of resi-
dential durations within regions, but this
approach needs more work to provide a
reliable method ofbias reduction.
Current Issues and
Recommendations
A general goal ofepidemiologic research is
to obtain the most information about pos-
sible health effects with minimal and/or
available resources. Given the difficulties
in estimating effects of specific environ-
mental exposures in human populations, this
goal isnoteasilyobtainedandoptimal research
strategies are not readily identified. Below, we
higlight severl current methodologic issues
in environmental epidemiology and make
somerecommendations forfuturework.
Study Design. No single design best
meets the objectives ofevery epidemiologic
study. In practice, study objectives are
shaped by many factors-current knowl-
edge, previous findings, institutional man-
dates, societal values, personal preferences,
etc. Although a prospective cohort study
might be expected, in general, to produce
less bias than would a hospital-based (pro-
portional) case-control study, the latter
design might be a rational choice in certain
situations. Even an ecologic design, despite
its limitations, might be appropriate; it may
betheonlypractical option atagiven time.
The challenges of environmental epi-
demiology, therefore, cannot be solved
simply by advocating the use of certain,
more expensive study designs. In addition
to committing more resources to the con-
duct ofepidemiologic research, we need to
develop new designs to meet specific objec-
tives more efficiently. For example, in
"Case-Control Study," we discussed the
use oftwo-stage designs to investigate asso-
ciations between rare diseases and rare
exposures and to control for covariates that
are relatively expensive to measure. New
approaches are also needed to identify
intermediate variables in observational
designs, to evaluate interaction effects
(effect modification) more efficiently, and
to deal with the problems ofnonparticipa-
tion, nonresponse, and noncompliance.
Another need in environmental epidemiol-
ogy is to understand better the relationship
between acute biological changes and
chronic health effects. For example, we
might combine experimental and observa-
tional methods to determine the extent to
which short-term changes in pulmonary
function caused byexposure to air pollutants
lead to chronicrespiratorydisease (2).
Bias Reduction. In nonrandomized
studies, it is important for the investigator
to deal with confounding in the analysis.
This is achieved by identifying potential
confounders in the design phase and mea-
suring them accurately in the studypopula-
tion. The prevention of selection bias,
however, is not so straightforward because
it depends on identifying all cases that
occur in awell-defined (base) population at
risk. When new cases occur infrequently
or when it is otherwise impractical to re-
examine enough individuals to detect all
new events, the prevention ofselection bias
depends on population surveillance and moni-
toring systems, such as population-based
tumor registries and industrial surveillance.
Although these systems may be expensive
to implement and operate, they are often
necessarytoreducethethreatofselectionbias.
Unfortunately, population-based sys-
tems may not be sufficient to prevent selec-
tion bias with diseases for which detection
depends critically on care seeking, symp-
tom reporting, and complex differential
diagnoses. A key problem is that not all
persons with an illness recognize their
symptoms and seek medical attention.
Thus, exposure effects observed for these dis-
eases inepidemiologicstudies might reflect the
effects ofthe exposure on illness behavior as
well astheeffectsonillnessoccurrence (100).
Another solution to incomplete or
inadequate case detection is to control ana-
lytically for methodologic covariates that
reflect differences in illness behavior. For
example, we might measure the individ-
ual's tendency to seek medical care and
treat this variable as a confounder. The
measurement of this covariate should be
independent of disease status; otherwise,
covariate adjustment will probably lead to
bias toward the null value. This approach
needs further development and evaluation.
An alternative strategy for studying dis-
eases that are difficult to detect in large pop-
ulations, such as musculoskeletal conditions,
is another type oftwo-stage design. In the
first stage, a large population is surveyed
cross-sectionally or longitudinally by ques-
tionnaires or interviews to identify persons
with symptoms characteristic ofthe disease.
The second stage involves case-control sam-
pling ofthe population to compare persons
with andwithout these symptoms (i.e., cases
and controls). In this stage, subjects are
given more definitive diagnostic tests to
identify true cases of the disease. By com-
paring diagnostic test results between
selected cases and controls, the investigators
can assess the validity of their symptom-
based criteria, suggest improvements in din-
ical diagnosis, and estimate exposure effects.
The latter objective requires the develop-
ment of statistical methods appropriate for
thesamplingstrategy.
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Quality ofMeasurement. As noted ear-
lier (see "Problems in Environmental
Epidemiology"), amajorchallenge in environ-
mental epidemiology is to measure accurately
each individual's exposure to suspected and
known risk factors for the disease under
study. In the absence ofpreviously validated
and inexpensive methods for measuring expo-
sures and covariates in large groups, it has
become common practice to use more than
one method or source ofinformation to mea-
sure these variables. Nevertheless, it usually is
not dear how different methods or sources of
information should becombinedorwhatdata
should be combined to minimize measure-
ment errors and estimation bias (4,101,102).
We need more methodologic research in this
area to provide guidelines for the measure-
ment ofspecific exposures in particular types
ofpopulations. One approach that might be
pursued with environmental exposures is to
combine ecologic data with self-reported data
on individual behaviors. For example, sup-
pose we collect ecologic data on pesticide
spraying and distribution throughout a large
region. We could then obtain from subjects
the location oftheirhomes; the typeandloca-
tion oftheirwork; their useofdfinkingwater;
and how often they swim, fish, and partici-
pate in other activities that would affect
their exposure topesticides intheregion.
Frequently, an accurate method does
exist for measuring an exposure, but the
application ofthis method to all subjects in a
population is prohibitively expensive or
infeasible. In such cases, many investigators
rely on less accurate methods for the total
sample and use the more accurate method in
a subsample ofsubjects. Assuming the accu-
rate method is perfectly valid (i.e., the gold
standard), the results of the validation sub-
study are used to quantify the amount of
measurement error, which is then used in the
total sample to correct for misdassification
bias involving the imperfect measure of
exposure. Some important issues need to be
considered to make this approach advanta-
geous. First, how many subjects and what
proportion of the total sample should be
included in the substudy (103,104)?
Second, how should we correct for exposure
misclassification in the analysis, especially
when the accurate method may not be per-
fectlyvalid orwhen thesubsample is not rep-
resentative of the total sample (see also
Prentice andThomas, this issue)?
Ecologic Inference. Because ofinherent
problems ofmeasurement, most epidemio-
logic studies of environmental exposures
are at least partly ecologic. When all data,
except a single exposure, are obtained at
the individual level, however, the ecologic
problem amounts to possible misclassifica-
tion bias, which is well understood and
often predictable. Yet, when the unit of
analysis is the group, the resulting ecologic
bias is far less predictable and can be rela-
tively severe in magnitude, especially when
other sources ofbias are present. Thus, in
general, ecologic analyses do not provide
very accurate estimates ofeffect. To make
ecologic findings more informative, there-
fore, we need more theoretical work to
specify the conditions for which ecologic
estimates can be expected to be reasonably
valid. With this information, we might
then collect additional data to check those
key assumptions or to correct ecologic esti-
mates. For example, by obtaining detailed
individual-level data on the exposure and
certain covariates in samples of selected
groups, we might be able to determine the
limits of ecologic bias in estimating the
exposure effect (see "Control forCovariates"
and Prentice andThomas, this issue).
Essentially, ecologic bias (aside from
within-group bias) occursbecausegroupaffili-
ation or the average exposure level of the
group affects disease occurrence indepen-
dently of exposure status at the individual
level (see "Ecological Bias"). The structural
effectsofsuchecologicvariables, iftheycan be
separated from other effects at the individual
level, might be informative, rather than just a
source oferror. Thus, byinduding both eco-
logic and individual-level predictors (possibly
of the same exposure) in the analysis, we
might enhance our understanding ofdisease
occurrence. This type ofcontextual or multi-
level analysis has been used extensively in
social science research (105-108) but rarely in
epidemiologic research (109). In addition, if
the effect ofa riskfactor is known from previ-
ous research, the results ofanecologic analysis
involving that risk factor could be used to
evaluate the potential or realized impact ofa
population intervention, which may not be
completely estimable at the individual level
(63). A more profound understanding of
ecologicbias, therefore, couldyieldbenefits to
otherpublic-health research.
Gene-EnvironmentInteractions. Because
both genetic and environmental factors con-
tribute to the etiology of most diseases, we
would typically expect factors ofeach type to
confound and/or modify the effect of the
other. We know, for example, that a combi-
nation ofboth environmental/personal factors
and genetic susceptibilities are sufficient for
thedevelopment ofcertain diseases. Yet stan-
dard methods ofepidemiologic research and
population genetics have not been well inte-
grated (110). As indicated in "Ecological
Bias," weneed newmethodsforincorporating
environmental variables in genetic (e.g., link-
age) analyses ofpedigree data. We also need
to understand better the relationship between
those parameters estimated in pedigree studies
and the effect parameters estimated in stan-
dard epidemiologic studies; and we need to
understand better how the estimates of
gene-environment interactions in pedigree
studies are biased by confounding, measure-
ment error, and family selection (ascertain-
ment). With this understanding, we can
devise new methods to prevent or control
bias. Analogously, the use offamily data in
standard epidemiologic designs (e.g., history
ofdisease and/or its risk factors in relatives)
requires further development in order to han-
die differences in familysize and composition
among subjects. With the recent advances in
molecular genetics, the integration of epi-
demiology and population genetics is likely to
becomemoreimportant inthefuture.
Sample Size andPower. As noted in
"Problems in Environmental Epidemiology,"
epidemiologic studies of environmental
exposures often require large sample sizes to
detect risk-factor effects with sufficiently
small statistical error. To address this con-
cern, researchers are usually expected to jus-
tify their proposed sample size by estimating
the power of their study for testing one or
more major hypotheses (i.e., the probability
ofdetecting an association of at least a cer-
tain magnitude with a designated Type I
error-alpha level typically set at 5%). This
is a rather straightforward procedure when
the power estimation is applied to two
dichotomousvariables (exposureanddisease)
(1,4,111). Yet all observational studies
require more complicated analyses to make
causal inferences - e.g., to deal with polyto-
mous, continuous, or time-dependent expo-
sures; covariateadjustment; the assessment of
interaction effects; matching; and other spe-
cial design features. Although methods of
power estimation do exist for many ofthese
complicating features, theyrequireadditional
specifications (assumptions) about which the
investigator is not likely to have adequate
information. Further development of these
methods would be useful, therefore, to iden-
tify techniques that are both practical and
informative in specific situations, including
ecologic studies for which sample size
requirements havereceivedlittle attention.
One parameter the investigator must
specify to justify the proposed sample size
is the magnitude of effect expected in the
data or the minimum effect regarded as
important to detect. In the absence ofpre-
vious epidemiologic studies involving simi-
lar exposure levels, the expected effect is
generally specified rather arbitrarily (e.g., a
Environmental Health Perspectives Supplements
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rate ratio of2). Sometimes, however, there
are exposure-response findings from ani-
mal studies or occupational studies with
higher exposure levels, which could be used
to estimate the environmental exposure
effect expected in the base population.
This approach, which also requires further
development, might allow research funds
to be allocated morejudiciously.
Data Analysis. Many of the recent
developments and ideas for new study
designs and data collection that were dis-
cussed in this article require parallel develop-
ments in statistical methods. For example,
the analyst might have to deal with complex
sampling strategies (as in two-stage designs);
missing, misclassified, and/or aggregated
data on relevant variables; time-dependent
covariates; lag periods between first expo-
sure and disease detection; incomplete case
detection; and a limited sample size that
severely restricts the number of covariates
treated simultaneously. Several of these
issues are covered further by Hatch and
Thomas and by Prentice and Thomas in
this issue. eX
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